News Image

Top movers in Tuesday's session

By Mill Chart

Last update: Oct 4, 2022

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.

Gainers

TickerChangeComment
EJH2.0K%E-HOME HOUSEHOLD SERVICE's (NASDAQ:EJH) stock price increased by 2.0K% to $1.83. In the last month the stock lost 50.58%.
BTB175.0%BIT BROTHER LTD (NASDAQ:BTB) rose 175.0% to $0.31 during Tuesday's after hours session. Shareholders saw the stock price going 32.1% lower in the past month.
TOPS79.2%TOP SHIPS INC's (NASDAQ:TOPS) stock price increased by 79.2% to $5.86. Shareholders saw the stock price going 42.53% lower in the past month.
AERC75.07%AEROCLEAN TECHNOLOGIES INC's (NASDAQ:AERC) stock price is advancing with 75.07% to a price of $5.62. Earlier today the company had a press release: BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Poshmark, Inc. (Nasdaq – POSH), First Eagle Alternative Capital BDC, Inc. (Nasdaq – FCRD), AeroClean Technologies (Nasdaq – AERC), Talos Energy Inc. (NYSE - TALO).
CNXA72.35%CONNEXA SPORTS TECHNOLOGIES's (NASDAQ:CNXA) stock price is advancing with 72.35% to a price of $0.5. In the last month the stock lost 68.64%.
ADVWW63.49%ADVANTAGE SOLUTIONS IN-CW25 (NASDAQ:ADVWW) rose 63.49% to $0.18 during Tuesday's after hours session. In the last month the share price dropped with 71.77%.
SNTI57.6%SENTI BIOSCIENCES INC's (NASDAQ:SNTI) stock price is advancing with 57.6% to a price of $3.94. In the last month the stock gained 26.9%.
INBX46.18%INHIBRX INC's (NASDAQ:INBX) shares rose 46.18% to $29.5. The stock is trading 24.88% higher than a month ago.
PEGY42.5%PINEAPPLE ENERGY INC's (NASDAQ:PEGY) shares rose 42.5% to $1.14 during Tuesday's session. In the last month the stock lost 64.07%.
APDN33.52%APPLIED DNA SCIENCES INC's (NASDAQ:APDN) stock price is advancing with 33.52% to a price of $1.5. In the last month the stock lost 59.57%.

Our top gainers screener will show you the full list.

Losers

TickerChangeComment
ASZ.W-99.75%AUSTERLITZ ACQ CL A -CW27's (NYSE:ASZ.W) stock price decreased by 99.75% to $0.0. In the last 3 months the share price dropped with 38.65%.
KALV-57.51%KALVISTA PHARMACEUTICALS INC's (NASDAQ:KALV) shares fell 57.51% to $6.05 during Tuesday's session. Yesterday the company had a press release: KalVista Pharmaceuticals Announces Termination of KVD824 Phase 2 KOMPLETE Trial for Prophylactic Treatment of Hereditary Angioedema.
OBLG-38.4%OBLONG INC's (NASDAQ:OBLG) shares fell 38.4% to $0.25. The stock is trading 54.14% higher than a month ago.
FNHC-37.02%FEDNAT HOLDING CO's (NASDAQ:FNHC) stock price is declining with 37.02% to a price of $0.3. The stock is trading 56.67% higher than a month ago.
FAZE-36.93%FAZE HOLDINGS INC's (NASDAQ:FAZE) stock price decreased by 36.93% to $5.14. In the last month the share price dropped with 53.24%.
VSTM-33.65%VERASTEM INC's (NASDAQ:VSTM) shares fell 33.65% to $0.58. A press release (Verastem Oncology Announces RAMP VS-6766 Clinical Trials and Corporate Updates) was released yesterday.
CRH.W-28.08%COHN ROBBINS HOLDINGS -CW25's (NYSE:CRH.W) stock price decreased by 28.08% to $0.02. The stock is trading 96.76% lower than a month ago.
BOA.W-27.27%BOA ACQUISITION CL A -CW28's (NYSE:BOA.W) stock price is declining with 27.27% to a price of $0.08. Shareholders saw the stock price going 85.67% higher in the past month.
TBLTW-26.71%TOUGHBUILT INDUSTRIES-CW23's (NASDAQ:TBLTW) shares fell 26.71% to $0.12. In the last 3 months the stock gained 47.43%.
BLEUR-20.7%BLUEACACIA LTD - RIGHTS's (NASDAQ:BLEUR) stock price decreased by 20.7% to $0.08. The stock is trading 22.27% lower than 3 months ago.

To see the full list of top losers you can use our top losers screener.

Back

SENTI BIOSCIENCES INC

NASDAQ:SNTI (5/1/2024, 4:28:25 PM)

After market: 0.38 0 (0%)

0.38

+0.02 (+5.56%)

SNTI News

News Imagea day ago - Senti Biosciences, Inc.Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)
News Imagea day ago - Senti Biosciences, Inc.Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)

Senti Bio today announced the publication of preclinical data that supports the design of the Phase 1 clinical trial of SENTI-202....

News Imagea month ago - InvestorPlaceSNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023

SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.

News Imagea month ago - BusinessInsiderSNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Senti Biosciences (NASDAQ:SNTI) just reported results for the fourth quarter of...

News Imagea month ago - Senti Biosciences, Inc.Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights
News Imagea month ago - Senti Biosciences, Inc.Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights

– IND for SENTI-202, a potential first-in-class logic-gated treatment for AML, cleared by the U.S. FDA; First patient dosing anticipated in the second...

News Image4 months ago - Seeking AlphaSenti Biosciences to reduce workforce by 37% (NASDAQ:SNTI)

Senti Biosciences plans to cut workforce by ~37% to prioritize investment in its cell therapy for acute myeloid leukemia, SENTI-202.

News Image4 months ago - Senti Biosciences, Inc.Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program
News Image4 months ago - Senti Biosciences, Inc.Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program

– Strategic resource allocation to focus investment on clinical development of SENTI-202 and SENTI-301A partnership in China; interim data from Phase 1...

News Image4 months ago - Senti Biosciences, Inc.Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
News Image4 months ago - Senti Biosciences, Inc.Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia

– First patient in Phase 1 clinical trial expected to be treated in Q2 2024 – – Initial clinical efficacy data expected by year-end 2024 and durability...

News Image5 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!

SNTI Links
Follow us for more